BackgroundThe conventional treatment of obesity presents unsatisfactory results on weight loss and its long-term sustainability, therefore bariatric surgery has been suggested as an effective therapy, determining sustainable long-term weight loss, reversal of components of cardiometabolic risk and improved quality and life expectancy.AimTo investigate the clinical component of the cardiometabolic risk in patients undergoing bariatric surgery assisted on outpatient basis.MethodsThe sample consisted of 47 patients with ages between 18 and 60 years, 72% females. Diabetes mellitus, hypertension, and dyslipidemia were prospectively evaluated by using the Assessment of Obesity-Related Co-morbidities scale.ResultsOccurred improvement in these co-morbidities within 12 months after surgery. Co-morbidities resolved were greater than those improved.ConclusionThe study revealed that the Assessment of Obesity-Related Co-morbidities is a system that can be effectively used to quantify the degree of reduction of the severity of the cardiometabolic risk in response to bariatric surgery.